Enalapril

Brand Names: Renitec

Drug Class: Angiotensin-converting enzyme (ACE) inhibitor

Overview

Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and heart failure. It works by inhibiting the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced aldosterone secretion. Clinical trials demonstrate improved survival and reduced hospitalizations in heart failure patients.

Mechanism of Action

Enalapril inhibits angiotensin-converting enzyme (ACE), preventing conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This results in vasodilation, reduced aldosterone secretion, decreased sodium and water retention, and lowered blood pressure.

Indications

  • Hypertension
  • Heart failure (to reduce mortality and hospitalizations)
  • Asymptomatic left ventricular dysfunction (to delay progression to symptomatic heart failure)

Common Doses

  • 2.5 mg
  • 5 mg
  • 10 mg
  • 20 mg

Dosage

Hypertension: Initial dose 5 mg once daily, adjust based on response (usual range 10-40 mg daily in 1-2 divided doses). Heart failure: Start at 2.5 mg once daily, titrate upward to target dose of 10-20 mg daily. Renal impairment requires dosage adjustment.

Contraindications

  • Hypersensitivity to enalapril or other ACE inhibitors
  • History of angioedema related to ACE inhibitor therapy
  • Hereditary or idiopathic angioedema
  • Concomitant use with aliskiren in patients with diabetes
  • Concomitant use with neprilysin inhibitors (e.g., sacubitril)

Side Effects

  • Dizziness
  • Headache
  • Fatigue
  • Cough
  • Hypotension
  • Hyperkalemia
  • Renal dysfunction
  • Angioedema
  • Rash
  • Nausea
  • Elevated liver enzymes

Interactions

  • Neprilysin inhibitors (increased angioedema risk)
  • Aliskiren (avoid in diabetes, increased hyperkalemia and renal impairment risk)
  • Diuretics (increased hypotension risk)
  • Potassium supplements/potassium-sparing diuretics (increased hyperkalemia risk)
  • NSAIDs (may reduce antihypertensive effect and increase renal impairment risk)
  • Lithium (increased lithium toxicity risk)

Counseling Points

  • Take at same time daily, with or without food
  • Report signs of angioedema (swelling of face, lips, tongue, throat) immediately
  • Monitor for dizziness, especially with initial doses
  • Avoid potassium supplements unless prescribed
  • Report persistent dry cough
  • Use effective contraception during treatment
  • Regular blood pressure monitoring required